Shattuck Labs to Report Fourth-Quarter and Full-Year 2022 Financial Results on February 23, 2023
AUSTIN, TX & DURHAM, NC, Feb. 16, 2023 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced it will report its fourth quarter and full year 2022 financial results and provide a general business overview on Thursday, February 23, 2023.
Related news for (STTK)
- MoBot alert highlights: NASDAQ: MOVE, NASDAQ: AIHS, NASDAQ: NXTT, NASDAQ: STTK, NASDAQ: IPDN (09/03/25 10:00 AM)
- Breaking News: MoBot’s Latest Update as of 09/03/25 09:00 AM
- Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/15/25 10:00 AM
- Breaking News: MoBot’s Latest Update as of 08/05/25 07:00 AM